Please provide your email address to receive an email when new articles are posted on . A novel adhesive-based wearable cardioverter defibrillator exceeded its safety and efficacy performance goals.

Credit: Element Sciences. The system uses a proprietary algorithm to detect and classify shockable arrhythmias. The Jewel Patch-WCD is designed to be worn continuously for up to a week at a time ...

A novel, water-resistant patch-wearable cardioverter-defibrillator is safe and effective for patients at risk for sudden cardiac arrest. HealthDay News — A novel, water-resistant patch-wearable ...

For patients with certain cardiovascular conditions and risk factors, sudden cardiac arrest is more than a theoretical concern. But over the past 25 years, the development of various types of ...

After securing approvals in the U.K. and Europe early last year, Element Science has now claimed a green light from the FDA for its wearable defibrillator patch, offering a non-invasive option for ...

The U.S. Food and Drug Administration today approved a new indication for the LifeVest wearable cardioverter defibrillator. The LifeVest is approved for certain children who are at risk for sudden ...

Medical devices and related software solutions maker ZOLL has introduced its next-generation LifeVest wearable cardioverter defibrillator (WCD) in the US. The latest device is the fifth LifeVest WCD, ...

KIRKLAND, Wash., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today announced primary results from the ...

SAN FRANCISCO--(BUSINESS WIRE)--Element Science, an innovative health technology company developing a pioneering digital wearable platform for high-risk cardiovascular patients, announced the ...

The wearable cardiac monitor and defibrillator developer Kestra Medical Technologies aims to raise about $154 million by going public on the Nasdaq, with plans to greatly scale up its commercial ...